These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8541002

  • 1. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
    Trevisan R, Tiengo A.
    Am J Hypertens; 1995 Sep; 8(9):876-83. PubMed ID: 8541002
    [Abstract] [Full Text] [Related]

  • 2. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P, Bilbous R, Mitchell T, O' Callaghan CJ, Viberti GC, Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group.
    Diabetes Care; 2000 Dec; 23(12):1823-9. PubMed ID: 11128360
    [Abstract] [Full Text] [Related]

  • 3. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 4. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 5. Impediment of the progressions of microalbuminuria and hyperlipidemia in normotensive type 2 diabetes by low-dose ramipril.
    Vongterapak S, Dahlan W, Nakasatien S, Anuntakulnatee T, Suppanich M, Kittipoom W, Surasingchaidet C, Tamwiwat C, Tepkasetkul M, Bunnag P, Ongphiphadhanakul B, Rajatanavin R, Himathongkam T.
    J Med Assoc Thai; 1998 Sep; 81(9):671-81. PubMed ID: 9737124
    [Abstract] [Full Text] [Related]

  • 6. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
    Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J, DIABHYCAR Study Investigators.
    BMJ; 2004 Feb 28; 328(7438):495. PubMed ID: 14960504
    [Abstract] [Full Text] [Related]

  • 7. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212
    [Abstract] [Full Text] [Related]

  • 8. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G, Mogensen CE, Groop LC, Pauls JF.
    JAMA; 1994 Jan 26; 271(4):275-9. PubMed ID: 8295285
    [Abstract] [Full Text] [Related]

  • 9. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J, Siddiqui MA, Ahmad H.
    Diabetes Care; 1997 Oct 26; 20(10):1576-81. PubMed ID: 9314638
    [Abstract] [Full Text] [Related]

  • 10. Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
    Fogari R, Mugellini A, Zoppi A, Gualtierotti R, Lazzari P, Derosa G, D'Angelo A.
    Expert Opin Pharmacother; 2013 Dec 26; 14(18):2463-73. PubMed ID: 24195786
    [Abstract] [Full Text] [Related]

  • 11. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 12. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
    Schnack C, Hoffmann W, Hopmeier P, Schernthaner G.
    Diabetologia; 1996 Dec 15; 39(12):1611-6. PubMed ID: 8960851
    [Abstract] [Full Text] [Related]

  • 13. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M.
    Ann Intern Med; 1993 Apr 15; 118(8):577-81. PubMed ID: 8452322
    [Abstract] [Full Text] [Related]

  • 14. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    Toto RD, Adams-Huet B, Fenves AZ, Mitchell HC, Mulcahy W, Smith RD.
    Am J Kidney Dis; 1996 Dec 15; 28(6):832-40. PubMed ID: 8957034
    [Abstract] [Full Text] [Related]

  • 15. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.
    Am J Hypertens; 1995 Aug 15; 8(8):808-14. PubMed ID: 7576397
    [Abstract] [Full Text] [Related]

  • 16. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM, Santoni JP, Thomas JR, van de Voorde K, Ketelslegers JM, Lambert AE.
    Diabete Metab; 1990 Aug 15; 16(1):30-6. PubMed ID: 2185055
    [Abstract] [Full Text] [Related]

  • 17. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.
    Ann Intern Med; 2003 Jul 15; 139(2):90-6. PubMed ID: 12859158
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL, Hanson C, Lucas C, Rosenblatt S, Rosenstock J, Whittier F, Wistran D, Riche C, Mulcahy WS.
    Clin Ther; 1993 Jul 15; 15(1):79-87. PubMed ID: 8458057
    [Abstract] [Full Text] [Related]

  • 19. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitán MC, Gil A.
    Am J Hypertens; 1994 Jan 15; 7(1):46-51. PubMed ID: 8136110
    [Abstract] [Full Text] [Related]

  • 20. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
    Borcea V, Morcos M, Isermann B, Henkels M, Ziegler S, Zumbach M, Amiral J, Längst KD, Seiz W, Ziegler R, Wahl P, Nawroth PP.
    Vasa; 1999 Aug 15; 28(3):172-80. PubMed ID: 10483322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.